EVA3_RHISA
ID EVA3_RHISA Reviewed; 86 AA.
AC P0C8E8;
DT 25-NOV-2008, integrated into UniProtKB/Swiss-Prot.
DT 25-NOV-2008, sequence version 1.
DT 25-MAY-2022, entry version 25.
DE RecName: Full=Evasin-3 {ECO:0000303|PubMed:18678732, ECO:0000303|PubMed:31167786, ECO:0000303|PubMed:31235521};
DE Short=EVA3 {ECO:0000303|PubMed:31167786};
DE Flags: Precursor;
OS Rhipicephalus sanguineus (Brown dog tick) (Ixodes sanguineus).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Acari;
OC Parasitiformes; Ixodida; Ixodoidea; Ixodidae; Rhipicephalinae;
OC Rhipicephalus; Rhipicephalus.
OX NCBI_TaxID=34632;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF N-TERMINUS, SUBUNIT, AND
RP FUNCTION.
RC TISSUE=Salivary gland;
RX PubMed=18678732; DOI=10.1084/jem.20072689;
RA Deruaz M., Frauenschuh A., Alessandri A.L., Dias J.M., Coelho F.M.,
RA Russo R.C., Ferreira B.R., Graham G.J., Shaw J.P., Wells T.N.C.,
RA Teixeira M.M., Power C.A., Proudfoot A.E.I.;
RT "Ticks produce highly selective chemokine binding proteins with
RT antiinflammatory activity.";
RL J. Exp. Med. 205:2019-2031(2008).
RN [2] {ECO:0007744|PDB:6I31}
RP X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 21-86, FUNCTION, AND DISULFIDE
RP BONDS.
RX PubMed=31167786; DOI=10.1074/jbc.ra119.008817;
RA Lee A.W., Deruaz M., Lynch C., Davies G., Singh K., Alenazi Y.,
RA Eaton J.R.O., Kawamura A., Shaw J., Proudfoot A.E.I., Dias J.M.,
RA Bhattacharya S.;
RT "A knottin scaffold directs the CXC-chemokine-binding specificity of tick
RT evasins.";
RL J. Biol. Chem. 294:11199-11212(2019).
RN [3] {ECO:0007744|PDB:6QJB}
RP STRUCTURE BY NMR OF 37-76, FUNCTION, AND DISULFIDE BONDS.
RX PubMed=31235521; DOI=10.1074/jbc.ra119.008902;
RA Denisov S.S., Ippel J.H., Heinzmann A.C.A., Koenen R.R., Ortega-Gomez A.,
RA Soehnlein O., Hackeng T.M., Dijkgraaf I.;
RT "Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8
RT interactions with glycosaminoglycans and CXCR2.";
RL J. Biol. Chem. 294:12370-12379(2019).
CC -!- FUNCTION: Salivary chemokine-binding protein which shows chemokine
CC neutralizing activity and binds to host chemokines CXCL1, CXCL2, CXCL3,
CC CXCL5, CXCL6 and CXCL8 (PubMed:18678732, PubMed:31167786,
CC PubMed:31235521). Binds to CXCL8 with 1:1 stoichiometry
CC (PubMed:31235521). Disrupts CXCL8 homodimer formation, disrupts the
CC glycosaminoglycan-binding site of CXCL8 and inhibits the interaction of
CC CXCL8 with CXCR2 (PubMed:31235521). {ECO:0000269|PubMed:18678732,
CC ECO:0000269|PubMed:31167786, ECO:0000269|PubMed:31235521}.
CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:18678732}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Hidden powers - Issue 99 of
CC November 2008;
CC URL="https://web.expasy.org/spotlight/back_issues/099";
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR PDB; 6I31; X-ray; 1.79 A; A/B=21-86.
DR PDB; 6QJB; NMR; -; A=37-76.
DR PDBsum; 6I31; -.
DR PDBsum; 6QJB; -.
DR AlphaFoldDB; P0C8E8; -.
DR BMRB; P0C8E8; -.
DR SMR; P0C8E8; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0019958; F:C-X-C chemokine binding; IDA:UniProtKB.
DR GO; GO:1900137; P:negative regulation of chemokine activity; IDA:UniProtKB.
DR GO; GO:0090074; P:negative regulation of protein homodimerization activity; IDA:UniProtKB.
PE 1: Evidence at protein level;
KW 3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW Secreted; Signal.
FT SIGNAL 1..20
FT /evidence="ECO:0000269|PubMed:18678732"
FT CHAIN 21..86
FT /note="Evasin-3"
FT /id="PRO_0000354058"
FT CARBOHYD 45
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 76
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 42..57
FT /evidence="ECO:0000269|PubMed:31167786,
FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31,
FT ECO:0007744|PDB:6QJB"
FT DISULFID 46..59
FT /evidence="ECO:0000269|PubMed:31167786,
FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31,
FT ECO:0007744|PDB:6QJB"
FT DISULFID 53..70
FT /evidence="ECO:0000269|PubMed:31167786,
FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31,
FT ECO:0007744|PDB:6QJB"
FT HELIX 34..36
FT /evidence="ECO:0007829|PDB:6I31"
FT STRAND 37..47
FT /evidence="ECO:0007829|PDB:6I31"
FT TURN 48..50
FT /evidence="ECO:0007829|PDB:6QJB"
FT STRAND 58..60
FT /evidence="ECO:0007829|PDB:6I31"
FT STRAND 66..75
FT /evidence="ECO:0007829|PDB:6I31"
SQ SEQUENCE 86 AA; 9145 MW; 7FD0823DD19450D4 CRC64;
MRALLARLLL CVLVVSDSKG LVSTIESRTS GDGADNFDVV SCNKNCTSGQ NECPEGCFCG
LLGQNKKGHC YKIIGNLSGE PPVVRR